Literature DB >> 24570959

Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes.

Alfredo Guglielmi1, Andrea Ruzzenente1, Francesca Bertuzzo1, Calogero Iacono1.   

Abstract

Surgical treatment of perihilar cholangiocarcinoma (PCC) is the treatment of choice that can achieve long term results. Unfortunately the presence of lymph node metastases is frequent and it is one of the major negative prognostic factors in patients submitted to surgery. In literature there are few data about the prognostic significance of location, number and ratio of involved nodes. Moreover guidelines about the extent of lymph node dissection are not available. In this commentary the data of literature about prognostic significance of lymph node involvement are described and analysed.

Entities:  

Keywords:  Cholangiocarcinoma; lymphnodes metastases; surgery

Year:  2013        PMID： 24570959      PMCID： PMC3924695          DOI： 10.3978/j.issn.2304-3881.2013.08.10

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


  20 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Surgical management of hilar cholangiocarcinoma: the Nagoya experience.

Authors:  Hideki Nishio; Masato Nagino; Yuji Nimura
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

3.  Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection.

Authors:  Y Kitagawa; M Nagino; J Kamiya; K Uesaka; T Sano; H Yamamoto; N Hayakawa; Y Nimura
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

4.  Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.

Authors:  D Tamandl; K Kaczirek; B Gruenberger; C Koelblinger; J Maresch; R Jakesz; T Gruenberger
Journal:  Br J Surg       Date:  2009-08       Impact factor: 6.939

5.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

6.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

7.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

8.  Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

9.  Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.

Authors:  Takukazu Nagakawa; Masato Kayahara; Seiyo Ikeda; Shunji Futakawa; Akira Kakita; Hirofumi Kawarada; Masaki Matsuno; Tadahiro Takada; Ken Takasaki; Hiroshi Tanimura; Seiki Tashiro; Yoshio Yamaoka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

10.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969
View more
  2 in total

1.  High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.

Authors:  Qi Sun; Chuanzong Zhao; Leizhou Xia; Zhaobin He; Zhihua Lu; Chuan Liu; Ming Jia; Jiayong Wang; Jun Niu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.

Authors:  Fabio Bagante; Thuy Tran; Gaya Spolverato; Andrea Ruzzenente; Stefan Buttner; Cecilia G Ethun; Bas Groot Koerkamp; Simone Conci; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Gerardo Vitiello; Jan N M IJzermans; Shishir K Maithel; George Poultsides; Alfredo Guglielmi; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2016-02-26       Impact factor: 6.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.